Creative Medical Price To Book Ratio Over Time
| CELZ Stock | USD 2.19 0.12 5.19% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Creative Medical Performance and Creative Medical Correlation. Creative |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Creative Medical. If investors know Creative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Creative Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.589 | Earnings Share (3.80) | Revenue Per Share 0.008 | Quarterly Revenue Growth (0.84) | Return On Assets (0.36) |
The market value of Creative Medical Tec is measured differently than its book value, which is the value of Creative that is recorded on the company's balance sheet. Investors also form their own opinion of Creative Medical's value that differs from its market value or its book value, called intrinsic value, which is Creative Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Creative Medical's market value can be influenced by many factors that don't directly affect Creative Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Creative Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Creative Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Creative Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Book Ratio Analysis
Compare Creative Medical Tec and related stocks such as Regen BioPharma, Therasense, and Enzolytics Price To Book Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SONN | (14.127) | (14.127) | (14.127) | 26.7252 | (14.127) | 8.3674 | 5.6854 | 4.952 | 4.8792 | 64.0697 | 5.3408 | (20.1031) | (105) | 4.8792 | 5.12 |
| ICU | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.413) | (0.9524) | (4.0826) | (0.6912) | (0.73) |
| ZVSA | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (18.7349) | (12.8261) | 0.1424 | 0.0792 | 0.0832 |
| REVB | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | (24.4 K) | 26.8001 | (1 K) | 3.4078 | 0.5151 | 0.54 |
| PALI | 4.3 K | 2.5 K | 818 | 2.2 K | 1.2 K | 1.7 K | 315 | 265 | 84.8479 | 32.7475 | (13.2346) | 1.3838 | 0.3667 | 0.3567 | 0.34 |
| QNRX | 0.5743 | 0.5743 | 0.5743 | 0.5743 | 0.5743 | 0.5743 | 1.9022 | 7.2167 | 3.6473 | 1.099 | (3.9276) | 10.9756 | 0.9292 | 0.781 | 0.74 |
| VRAX | (196) | (196) | (196) | (196) | (196) | (196) | (196) | (196) | (196) | (196) | (347) | (212) | 0.81 | 0.2748 | 0.29 |
| UNCY | (32.9322) | (32.9322) | (32.9322) | (32.9322) | (32.9322) | (32.9322) | (32.9322) | (32.9322) | (32.9322) | (47.6528) | (28.5415) | 1.8741 | (17.4481) | (5.5901) | (5.87) |
| ADXN | 4.5988 | 1.2189 | 4.7352 | 11.1454 | 9.8755 | 18.5842 | 96.0631 | 22.0747 | 1.3593 | 1.6959 | 3.6343 | 2.0958 | 0.9252 | 2.9841 | 2.83 |
| SNGX | 82.7226 | 14.3025 | 30.1057 | (1.6 K) | (1.6 K) | (1.6 K) | 0.7391 | 2.1579 | 1.8046 | 19.2815 | 9.4027 | 2.4713 | (7.8717) | 2.3298 | 2.45 |
| ATXI | (1 K) | (1 K) | (1 K) | (1 K) | (1 K) | (1 K) | (663) | 92.9509 | (6.6 K) | 1.7 K | 3.1 K | 335 | 48.6834 | 1.0767 | 1.13 |
| CDIO | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 10.6945 | 0.7608 | 10.6777 | 10.14 |
Creative Medical Tec and related stocks such as Regen BioPharma, Therasense, and Enzolytics Price To Book Ratio description
A ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share.My Equities
My Current Equities and Potential Positions
| Creative Medical Technology | CELZ |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Arizona; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.19
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.